ISTODAX Trademark

Trademark Overview

On Monday, February 8, 2010, a trademark application was filed for ISTODAX with the United States Patent and Trademark Office. The USPTO has given the ISTODAX trademark a serial number of 77930626. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, December 26, 2019. This trademark is owned by Astellas Pharma Inc.. The ISTODAX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations as an anti-cancer drug for human uses
istodax

General Information

Serial Number77930626
Word MarkISTODAX
Filing DateMonday, February 8, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, December 26, 2019
Registration Number3874931
Registration DateTuesday, November 9, 2010
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 29, 2010

Trademark Statements

Description of MarkThe mark consists of "ISTODAX" with a blue arc to the left of the blue "I" with the dot of the "I" in green.
Goods and Servicespharmaceutical preparations as an anti-cancer drug for human uses
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 17, 2010
Primary Code005
First Use Anywhere DateMonday, March 1, 2010
First Use In Commerce DateMonday, March 1, 2010

Trademark Owner History

Party NameCELGENE CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 26, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, December 26, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, December 26, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, December 26, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 11, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, November 9, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, January 14, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, January 14, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 14, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 9, 2015TEAS SECTION 8 & 15 RECEIVED
Monday, November 9, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 9, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, October 6, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 5, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 5, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 28, 2010STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 31, 2010USE AMENDMENT FILED
Tuesday, September 28, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 31, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, August 24, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 29, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2010PUBLISHED FOR OPPOSITION
Tuesday, May 25, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 25, 2010ASSIGNED TO LIE
Monday, May 17, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 10, 2010ASSIGNED TO EXAMINER
Thursday, February 18, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, February 17, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 11, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

istodax human uses drug cancer preparations anti pharmaceutical